Amarin - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeAmarin
Amarin logo

Amarin

0 followers

AMRN

Performance

About Amarin

Amarin is a global pharmaceutical company focused on cardiovascular health, pursuing therapies to cost-effectively address cardiovascular disease and improve patient outcomes worldwide. The company emphasizes scientific breakthroughs and has developed products and pipeline programs aimed at lipid management and cardiovascular protection. It operates with a global footprint, providing information and updates through investor relations, science and health channels, and patient-focused resources. Amarin brands include VASCEPA and REDUCE-IT-related initiatives, reflecting its commitment to advancing cardiovascular care globally.

Recent News

Recent Deals

No recent deals for this company.

Key Team Members

Peter Fishman

Senior Vice President, Chief Financial Officer

Steven Ketchum

Executive Vice President, President R&D, Chief Scientific Officer

David Keenan

Executive Vice President, Chief Operating Officer

Eric Boothe

Senior Vice President, Corporate Development

Jonathan Provoost

Executive Vice President, Chief Legal & Compliance Officer

Key Facts

HQ Location

Dublin, Ireland

Founded

1991

Employees

201 - 500

Status

Public

Website

https://amarincorp.com